eli lilly sues compounders for selling unapproved copies of tirzepatide

eli lilly sues compounders for selling unapproved copies of tirzepatide compounding pharmacies over Mounjaro versions Lilly finds impurity in compounded

Name: eli lilly sues compounders for selling unapproved copies of tirzepatide compounding pharmacies over Mounjaro versions Lilly finds impurity in compounded
Brand: esh7enle.com
SKU: 44869264373
Price: 26.71 USD
Availability: InStock
Rating: 4.4599 (20 reviews)

SKU: 44869264373

4.5

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 22 - Aug 27

Description

We continue to stay up to speed on the newest research and advances in the field to guarantee that our patients receive the best possible care

Toxicology 382:7583

Each bottle contains 30 capsules, enough for one full month of use at the recommended daily serving of one capsule per day

Eli Lillys Mounjaro (tirzepatide) was approved for treating diabetes in the US, Canada and Europe in 2022, and brought in sales of almost $500 million (400 million) last year